Phase 3 ALS confirmatory study assessing CNM-Au8
Latest Information Update: 28 Dec 2023
At a glance
- Drugs CNM Au8 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
Most Recent Events
- 28 Dec 2023 New trial record
- 20 Dec 2023 According to Clene Inc media release, the company plans to launch this trial in 2024